Comparison of the triglyceride-waist circumference and the C-reactive protein-waist circumference indices in nascent metabolic syndrome.

C-reactive protein Metabolic syndrome adiposity inflammation triglycerides visceral fat waist circumference

Journal

International journal of physiology, pathophysiology and pharmacology
ISSN: 1944-8171
Titre abrégé: Int J Physiol Pathophysiol Pharmacol
Pays: United States
ID NLM: 101521074

Informations de publication

Date de publication:
2021
Historique:
received: 16 07 2021
accepted: 23 08 2021
entrez: 6 12 2021
pubmed: 7 12 2021
medline: 7 12 2021
Statut: epublish

Résumé

The Hypertriglyceridemia waist (HTGW) appears to be a valid measure of visceral adiposity, metabolic syndrome (MetS), type 2 diabetes mellitus (T2DM) and atherosclerotic cardiovascular disease (ASCVD). Since the cut points differ for different race groups recent studies have instead used the simplified product of triglycerides and waist circumference (TG.WC). In our patients with nascent MetS (without the confounding of T2DM, ASCVD, smoking and macro-inflammation) we found that only 41% had an increased HTGW. Since MetS is a pro-inflammatory disorder we compared the product of CRP to WC (CRP.WC) to TG.WC in our patients with nascent MetS as biomarkers. Patients with MetS (n=58) and matched controls (n=44) were recruited. Fasting blood samples were obtained for routine laboratories including the lipid profile, insulin, and adipokines. Both the TG.WC and CRP.WC indices were significantly increased in MetS and both increased with increasing severity of MetS. Whilst both correlated with cardio-metabolic features and insulin resistance, only the CRP.WC correlated significantly with adiponectin, an adipokine largely deriving from visceral adipose tissue. The TG.WC correlated with LDL-cholesterol which was not increased in this group. Receiver Operating Characteristic (ROC) curve analysis showed that both ratios showed good discrimination for MetS with no significant differences between ratios. Thus both the TG.WC and CRP.WC indices are significantly increased in patients with nascent MetS and appear to be valid biomarkers of MetS.

Identifiants

pubmed: 34868462
pmc: PMC8611242

Types de publication

Journal Article

Langues

eng

Pagination

126-131

Informations de copyright

IJPPP Copyright © 2021.

Déclaration de conflit d'intérêts

None.

Références

Metab Syndr Relat Disord. 2014 Dec;12(10):503-7
pubmed: 25162912
Circulation. 2004 Jun 15;109(23):2818-25
pubmed: 15197153
Eur Rev Med Pharmacol Sci. 2015 Jan;19(1):113-8
pubmed: 25635983
Physiol Rev. 2013 Jan;93(1):359-404
pubmed: 23303913
Diabetes Metab Res Rev. 2021 Mar;37(3):e3383
pubmed: 32652811
Metabolism. 2009 Aug;58(8):1123-30
pubmed: 19481769
J Am Heart Assoc. 2018 Apr 13;7(8):
pubmed: 29654193
J Clin Endocrinol Metab. 2011 Nov;96(11):E1782-8
pubmed: 21865369
Lipids Health Dis. 2014 Feb 23;13:38
pubmed: 24558974
J Clin Endocrinol Metab. 2013 Mar;98(3):E514-7
pubmed: 23303213
Am J Physiol Endocrinol Metab. 2019 Mar 1;316(3):E504-E509
pubmed: 30620639
J Diabetes Investig. 2016 Nov;7(6):860-866
pubmed: 27180654
J Diabetes Res. 2020 Dec 2;2020:9157430
pubmed: 33344653
Diabetes Metab Syndr Obes. 2020 Aug 18;13:2899-2907
pubmed: 32884316
Clin Chim Acta. 2019 Sep;496:35-44
pubmed: 31229566
J Clin Endocrinol Metab. 2012 Oct;97(10):E1844-50
pubmed: 22872691
BMC Endocr Disord. 2020 Feb 27;20(1):29
pubmed: 32103744
Can J Cardiol. 2007 Oct;23 Suppl B:23B-31B
pubmed: 17932584
Circulation. 2009 Oct 20;120(16):1640-5
pubmed: 19805654
Diabetologia. 2012 Sep;55(9):2319-26
pubmed: 22688349
Diabetes Metab Syndr. 2020 Jan - Feb;14(1):3-9
pubmed: 31805471
Diabetes Metab Res Rev. 2021 Sep;37(6):e3403
pubmed: 32886844
Diabetes Care. 2012 Apr;35(4):900-4
pubmed: 22357188
Diabetes Care. 2009 Oct;32(10):1916-20
pubmed: 19592623
Am J Clin Pathol. 2008 May;129(5):815-22
pubmed: 18426744
Arterioscler Thromb Vasc Biol. 2008 Jun;28(6):1039-49
pubmed: 18356555

Auteurs

Ishwarlal Jialal (I)

Veterans Affairs Medical Center Mather 95655, CA, USA.

Beverley Adams-Huet (B)

UT Southwestern Medical Center Dallas 75390, TX, USA.

Classifications MeSH